GH Research PLC

As of June 30, 2026, GH Research Plc carries a market capitalization of 1.62B, placing it among publicly traded companies globally. Its enterprise value stands at 1.30B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

GH Research Plc's next confirmed earnings release is scheduled for November 5, 2026.

As of June 30, 2026, GH Research Plc has 68.64M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, GH Research Plc maintains a current ratio of 28.70, meaning it holds 28.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.10, indicating conservative leverage, while an interest coverage ratio of -2,540.25 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, GH Research Plc posted a negative return on equity (ROE) of -18.79, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -18.16, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 67.25, a quick read on workforce productivity versus industry peers.

As of the close on October 22, 2026, GH Research Plc's stock has gained approximately 53.70% over the past 52 weeks. The 50-day moving average sits at 21.99, while the 200-day moving average is 18.68.

Over the twelve months ended June 30, 2026, GH Research Plc generated - - in revenue and converted that into -54.50M in net income, yielding earnings per share of -0.86. EBITDA reached -62.26M, while operating income came in at -62.52M.

As of June 30, 2026, GH Research Plc holds 317.43M in cash and equivalents against 315,108.00 in total debt, resulting in a net debt position of -302.02M. Total book value stands at 314.66M, with working capital of 311.58M providing operational flexibility.

GH Research Plc produced -45.26M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -120,791.40 in capital expenditures, free cash flow totaled -45.38M - equivalent to -0.72 per share.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -3.04: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -6.04, meaning GH Research Plc raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, GH Research Plc has an Altman Z-Score of 86.16, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.